UMEM Educational Pearls

Category: Cardiology

Title: GPIIB/IIIA inhibitors in NSTE-ACS

Keywords: GPIIB/IIIA inhibitors, acute coronary syndrome, antiplatelet medications (PubMed Search)

Posted: 8/26/2007 by Amal Mattu, MD (Updated: 11/19/2019)
Click here to contact Amal Mattu, MD

The 2007 ACC/AHA Guidelines for management of patients with unstable angina and non-STEMI were just released. They once again suggest the use of abciximab (Reopro) as the preferred glycoprotein receptor antagonist in patients that are going for PCI. If there is an anticipated delay to PCI, then eptifibatide (Integrilin) or tirofiban (Aggrastat) are preferred. The best evidence for these medications is in patients being managed invasively rather than just medically.